Search results
Why Things Could Get Worse for Pfizer Stock Before They Get Better | The Motley Fool
The Motley Fool· 2 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (PFE 0.20%) stock was a hot buy...
New COVID subvariants are rising: How bad will California get hit this summer?
Los Angeles Times· 6 days agoAs the new FLiRT family of coronavirus subvariants takes hold, early signs are pointing to a summer...
L.A. Affairs: For years, we were Matt & Ted. Except I wasn't Ted. I was Amie
LA Times via Yahoo News· 7 hours agoIt was quite a party. @amie_in_blue L.A. AffairsLAAffairs@latimes.com. You can find submission...
COVID shots should target JN.1 or newer variants in 2024-25 campaign, US FDA advisers say
Reuters· 2 days agoAdvisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor of...
House fire in Northwest Austin
FOX 7 Austin· 7 hours agoAustin fire crews responded to a house fire Friday morning in Northwest Austin.
How 1301B7 Could Contribute To Advanced Vaccine Development
Forbes· 14 hours agoIn the ongoing Omicron era, a new COVID-19 antibody could renew optimism for urgently required...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 4 days agoWith sales of the Cambridge drugmaker’s Covid-19 vaccine declining as the pandemic becomes endemic,...
This Personality Change Could Actually Be a Sign of Infection, According to Doctors
Parade via Yahoo News· 2 days agoButler says. However, people with...says. For instance, Dr. Crowder suggests reviewing CDC...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Colorado Springs Gazette· 4 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
The Push to Get More People Into Long COVID Studies
Medscape· 4 days agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...